SARS-CoV-2 Variants and Global Population Vulnerability SARS-CoV-2 Variants and Global Population Vulnerability

SARS-CoV-2 Variants and Global Population Vulnerability

Diagnostic Strategies, Vaccine Development, and Therapeutic Management

    • USD 249.99
    • USD 249.99

Descripción editorial

SARS-CoV-2, the coronavirus responsible for COVID-19, wreaked havoc on the world; it could both spread easily and mutate rapidly, leading to the decrease in the effectiveness of newly developed vaccines over time. The detection of these mutated variants and the development of more efficient vaccines requires significant effort and increased knowledge in this field. This new book, SARS-CoV-2 Variants and Global Population Vulnerability: Diagnostic Strategies, Vaccine Development, and Therapeutic Management, provides detailed and systemic information regarding the biology and immunophysiology of SARS-CoV-2 and highlights the global vulnerability of the world population to SARS-CoV-2 infection and COVID-19.

The book covers different aspects pertaining to the SARS-CoV-2 variants and their relation to global vulnerability. Chapters discuss the diagnostics, vaccine development, and therapeutic management starting from the zoonotic origin, organization, and transmission of SARS-CoV-2, lifestyle and immunophysiology of the virus, detection and diagnosis techniques, and analytical techniques. The book also observes the global impact of Delta and Omicron SARS-CoV-2 variants. It looks at the drug repurposing and new drug discovery routines for the emerging variants. It presents strategies for fast-track vaccine development, the roles of nasal vaccines and nucleic acid vaccines for COVID-19 management, monoclonal antibody therapy for the diseases management, along with the use of dietary supplements and nutraceuticals, herbal drugs, and other alternative remedies for COVID-19 management. The book also considers the social and environmental impacts of SARS-CoV-2 variants and the current challenges, outlining aspects that can help in developing more efficacious means for controlling SARS-CoV-2 in the future.

Key highlights:
Discusses SARS-CoV-2 variants, diagnosis strategies, vaccine development, and the therapeutic management of the disease Provides comprehensive coverage of SARS-CoV-2 virus and variants
With its unique and thorough take on the subject, this book is an important resource of know-how for investigators working in this area. Professionals from the pharmaceutical industry as well as students, research scholars, doctors, and other healthcare professionals will find this book of particular value.

GÉNERO
Técnicos y profesionales
PUBLICADO
2024
5 de julio
IDIOMA
EN
Inglés
EXTENSIÓN
612
Páginas
EDITORIAL
Apple Academic Press
VENDEDOR
Taylor & Francis Group
TAMAÑO
29.7
MB
Recent Advancements in Tuberculosis Drug Discovery Recent Advancements in Tuberculosis Drug Discovery
2025
Data Science in Pharmaceutical Development Data Science in Pharmaceutical Development
2025
Pharmaceutical Microemulsions for Parenteral Delivery Pharmaceutical Microemulsions for Parenteral Delivery
2025
Viral Vectors for Vaccine Delivery Viral Vectors for Vaccine Delivery
2025
Emerging Pathways of Vaccine Adjuvants Emerging Pathways of Vaccine Adjuvants
2025
Nanocarrier Vaccines Nanocarrier Vaccines
2024